2m 2m 2m 2m 2m 2m 2m
Earth Science Te (ETST)
OTC
$0.18+$0.004 (+2.24%)
Price as of Jun 03, 2026- $51.7MMarket Cap
- 18.60%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Earth Science Te (ETST)
$0.18+$0.004 (+2.24%)
Annual
Quarterly
03/31/2025 | 03/31/2024 | 03/31/2023 | 03/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 32.8M +48,832.96% | -67,207 -238.47% | 48,537 +243.67% | 14,123 -89.98% | |
Cost of Revenue | 8.8M +113.75% | 4.1M +15,480.08% | 26,477 +16.95% | 22,639 -77.58% | |
Gross Profit | 24.3M +210.41% | 7.8M +35,387.29% | 22,060 +359.04% | -8,516 -121.33% | |
Sales and Marketing Expense | 836,860 +3,209.97% | 25,283 +213.14% | 8,074 +120.90% | 3,655 N/A | |
Research and Development Expense | N/A N/A | N/A N/A | 0 N/A | N/A N/A | |
Depreciation and Amortization Expense | 151,654 +1.27% | 149,749 +756.15% | 17,491 +622.47% | 2,421 0.00% | |
Total Operating Expenses | 20.9M +200.63% | 6.9M +623.46% | 958,743 +339.41% | 218,190 -94.97% | |
Operating Profit | 3.4M +277.70% | 892,349 +195.27% | -936,683 +313.17% | -226,706 -94.73% | |
Interest Income | 17 N/A | N/A N/A | 618,711 -82.25% | 3.5M +856,576.17% | |
Interest Expense | -21,189 -68.47% | -67,207 +41.69% | -47,433 +335.13% | -10,901 +128.77% | |
Interest Income and Expense and Net | -21,172 -68.50% | -67,207 -111.76% | 571,278 -83.56% | 3.5M +79,856.10% | |
Total Nonoperating Income and Expense | -21,189 -68.47% | -67,207 -111.76% | 571,278 -83.20% | 3.4M +4,294.43% | |
Income before Taxes | 3.4M +308.46% | 825,142 +325.82% | -365,405 -111.52% | 3.2M +172.40% | |
Income Taxes | 116,776 +798.07% | 13,003 N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | N/A N/A | 812,139 +322.26% | -365,405 -111.52% | 3.2M +172.40% | |
Net Income from Continuing Operations Applicable to Common | 3.4M +308.46% | 825,142 +325.82% | -365,405 -111.52% | 3.2M +172.40% | |
Basic EPS and Net Income | 0.01 +266.67% | 0.003 +200.00% | -0.003 -105.00% | 0.06 +175.00% | |
Diluted EPS and Net Income | 0.01 +266.67% | 0.003 +200.00% | -0.003 -105.00% | 0.06 +175.00% | |
Basic Weighted Average Shares | 303.5M -1.99% | 309.7M +112.31% | 145.9M N/A | N/A N/A | |
Diluted Weighted Average Shares | 303.5M -1.99% | 309.7M +112.31% | 145.9M N/A | N/A N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.5M +111.15% | 697,721 +1,851.34% | 35,756 +32.71% | 26,942 +66.71% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 1.5M +111.15% | 697,721 +1,851.34% | 35,756 +32.71% | 26,942 +66.71% | |
Total Current Assets | 3.1M +147.21% | 1.3M +2,634.34% | 46,016 +70.80% | 26,942 -38.78% | |
Accumulated Depreciation | 87,482 +112.08% | 41,250 +500.52% | 6,869 N/A | N/A N/A | |
Property and Plant and Equipment and Net | 1.4M +922.60% | 135,352 -5.49% | 143,213 +8,265.25% | 1,712 0.00% | |
Total Long-Term Assets | 1.4M +922.60% | 135,352 -5.49% | 143,213 +186.43% | 50,000 +165.34% | |
Total Assets | 7.1M +82.07% | 3.9M +42.28% | 2.7M +3,445.49% | 76,942 +19.17% | |
Income Taxes Payable | 88,427 N/A | N/A N/A | 67,863 N/A | N/A N/A | |
Total Short-Term Debt | 210,080 +586.72% | 30,592 -94.94% | 604,767 +10.50% | 547,283 -1.67% | |
Total Current Liabilities | 3.1M +111.66% | 1.5M +13.71% | 1.3M -30.55% | 1.9M -63.03% | |
Total Long-Term Debt | 31,427 -96.90% | 1.0M +395.86% | 204,408 -55.05% | 454,717 N/A | |
Total Long-Term Liabilities | 69,305 +14.44% | 60,559 -37.40% | 96,743 N/A | N/A N/A | |
Total Liabilities | 3.2M +97.03% | 1.6M +1.47% | 1.6M -14.55% | 1.9M -63.03% | |
Retained Earnings | -27.7M -6.46% | -29.7M -2.67% | -30.5M +1.14% | -30.1M -9.53% | |
Total Stockholders Equity | 3.9M +71.21% | 2.2M +100.91% | 1.1M +162.01% | -1.8M -64.08% | |
Total Shares Outstanding | 294.3M -5.06% | 310.0M +9.68% | 282.6M +424.79% | 53.9M +5.83% | |
Cash Flow | |||||
Cash from Operating Activities | 4.4M +262.48% | 1.2M +219.06% | -1.0M +502.67% | -168,106 -14.53% | |
Capital Expenditures | N/A N/A | 26,520 N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -1.9M +6,994.08% | -26,520 N/A | N/A N/A | 1,712 N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -1.7M +231.26% | -517,886 -150.94% | 1.0M +487.02% | 173,175 -4.91% | |
Financials Ratio | |||||
Gross Margin | 73.08% -98.83% | 6,237.96% +13,624.92% | 45.45% +175.37% | -60.30% -312.76% | |
Operating Margin | 10.29% +100.78% | -1,327.76% -31.20% | -1,929.83% +20.22% | -1,605.23% -47.43% | |
Return on Assets | N/A N/A | 24.58% +194.32% | -26.05% -100.58% | 4,484.98% +212.10% | |
Return on Equity | N/A N/A | 48.21% -54.75% | 106.55% +214.71% | -92.89% -162.01% | |
Revenue Growth | 48,832.96% +20,578.00% | -238.47% -197.86% | 243.67% +370.82% | -89.98% +22.89% | |
Current Ratio | 0.99 +16.80% | 0.85 +2,304.55% | 0.04 +146.15% | 0.01 +66.28% | |
Cash Ratio | 0.47 -0.26% | 0.47 +1,613.14% | 0.03 +91.61% | 0.01 +346.88% | |
Debt-to-Equity Ratio | 0.06 -86.49% | 0.46 -35.78% | 0.72 +230.23% | -0.55 N/A | |
Debt-to-Assets Ratio | 0.03 -87.29% | 0.27 -9.31% | 0.30 -97.72% | 13.02 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow